01-10-2011 | PHASE I STUDIES
Phase I trial of oblimersen (Genasense®) and gemcitabine in refractory and advanced malignancies
Published in: Investigational New Drugs | Issue 5/2011
Login to get access01-10-2011 | PHASE I STUDIES
Published in: Investigational New Drugs | Issue 5/2011
Login to get access